In the present study, we found that Ano1 expression levels were not correlated with tumor size, histological grade, and lymph node metastasis in all breast cancer patients as well as those with different ER, PR, and HER2 status. Here, ESR1 is linked to metastatic malignant neoplasm in the lymph nodes.